A systems biology approach for studying neurodegenerative diseases

Simon Lam, Abdulahad Bayraktar, Cheng Zhang, Hasan Turkez, Jens Nielsen, Jan Boren, Saeed Shoaie, Mathias Uhlen, Adil Mardinoglu*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Citations (Scopus)

Abstract

Neurodegenerative diseases (NDDs), such as Alzheimer's (AD) and Parkinson's (PD), are among the leading causes of lost years of healthy life and exert a great strain on public healthcare systems. Despite being first described more than a century ago, no effective cure exists for AD or PD. Although extensively characterised at the molecular level, traditional neurodegeneration research remains marred by narrow-sense approaches surrounding amyloid β (Aβ), tau, and α-synuclein (α-syn). A systems biology approach enables the integration of multi-omics data and informs discovery of biomarkers, drug targets, and treatment strategies. Here, we present a comprehensive timeline of high-throughput data collection, and associated biotechnological advancements and computational analysis related to AD and PD. We hereby propose that a philosophical change in the definitions of AD and PD is now needed.

Original languageEnglish
Pages (from-to)1146-1159
Number of pages14
JournalDRUG DISCOVERY TODAY
Volume25
Issue number7
DOIs
Publication statusPublished - Jul 2020

Fingerprint

Dive into the research topics of 'A systems biology approach for studying neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this